Semaglutide
A GLP-1 receptor agonist studied for appetite regulation and metabolic research.
View Protocol →
← Compound Library
Protocol Collection
Weight Loss: GLP Pathway
GLP-1 and metabolic compounds studied for appetite regulation and fat loss, from the flagship GLP-1 agonists to adjunct fat-metabolism and appetite-suppressant peptides. For research purposes only.
Tirzepatide
A dual GIP and GLP-1 receptor agonist researched for metabolic and weight-management pathways.
View Protocol →AOD-9604
A stabilized form of HGH Fragment 176-191 studied for fat metabolism without affecting blood sugar or IGF-1.
View Protocol →Tesofensine
An oral appetite-suppressant compound studied for weight loss, usable with or between GLP-1s.
View Protocol →5-Amino-1MQ
An oral NNMT inhibitor studied for fat loss, metabolic rate, and NAD+ support. A small-molecule capsule, not a peptide.
View Protocol →For research and educational purposes only. This information is not medical advice.